Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients April Smith; Brian Henriksen; Andrew Cohen Disclosures Am J Health Syst Pharm. 2011;68 (23):2241-2247.

Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients April Smith; Brian Henriksen; Andrew Cohen Disclosures Am J Health Syst Pharm. 2011;68 (23):2241-2247. 0 ...

Both control and Roux-en-Y gastric bypass operated study group had a pair of electrodes placed on three points of the remaining stomach: fundus, body and antrum. Data registration was performed after ...

The significant weight loss following Roux-en-Y gastric bypass (RYGB) has been extensively reported 2. At first, it has been regarded as an effect of the diminishment in the volumetric capacity of the ...

Roux-en-Y gastric bypass, the bariatric operation performed most often in the US, is considered a restrictive procedure with a small component of malabsorption. A small gastric pouch (30 ml ...